Light And Dark Studio / Shutterstock.com
PDL BioPharma has sued Merck Sharp & Dohme (MSD) in a complaint that centres on a now-expired patent directed to treating melanoma.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Merck Sharp & Dohme, patent infringement, PDL BioPharma, Keytruda, melanoma, US District Court for the District of New Jersey